Interesting facts
Interesting Facts About [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate
The compound [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate is a fascinating molecule with significant relevance in both organic chemistry and pharmaceutical applications. Here are some exciting aspects of this compound:
- Structural Complexity: The compound features a pyrroloindole framework, which is known for its intriguing structural and functional properties. This kind of heterocyclic compound often exhibits unique biological activities.
- Biological Significance: Compounds containing indole rings, particularly those with modifications like the trimethyl group in this compound, are often studied for their roles in medicinal chemistry. They can mimic biological molecules and potentially lead to new drug discoveries.
- Functional Groups: With the presence of a carbamate moiety, this compound may exhibit certain reactivities, making it a candidate for further chemical transformations and possibly enhancing its pharmacological profile.
- Stereochemistry: The specified stereochemical configuration, with (3aR,8bS), suggests that this compound could interact with biological systems in a specific manner, highlighting the importance of chirality in drug design.
- Research Potential: Given the increasing interest in natural product synthesis and the design of synthetic analogs, this compound may serve as a valuable scaffold in the search for new therapeutic agents.
In summary, [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate stands out not only for its structural attributes but also for its potential applications in advancing medicinal chemistry and understanding complex biochemical interactions. As a chemistry student or a scientist, exploring such compounds can lead to insightful discoveries that impact various fields.
Synonyms
physostigmine
Eserine
57-47-6
Antilirium
Esromiotin
Physostol
(-)-physostigmine
Ezerin
Calabarine
Fysostigmin
Erserine
cogmine
eserin
Eserinum
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate
Eserolein, methylcarbamate (ester)
CCRIS 3422
HSDB 3161
MCV 4484
EINECS 200-332-8
UNII-9U1VM840SP
NIH 10421
NSC 30782
NSC-30782
9U1VM840SP
CS 58525
DTXSID3023471
Methyl-carbamic acid, ester with eseroline
Carbamic acid, methyl-, ester with eseroline
MCV-4484
CHEMBL94
Physostigmine [USP:BAN]
DTXCID603471
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-
CHEBI:27953
NSC30782
1,2,3,3abeta,8abeta-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)-indol-5-yl methylcarbamate
(3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol methylcarbamate (ester)
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)
NCGC00093889-03
Physostigmine (USP:BAN)
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-
PHYSOSTIGMINE (MART.)
PHYSOSTIGMINE [MART.]
Fysostigmin [Czech]
PHYSOSTIGMINE (USP IMPURITY)
PHYSOSTIGMINE [USP IMPURITY]
CHEMBL537674
(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate
CAS-57-47-6
[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate
Eserolein, methylcarbamate
RCRA waste no. P204
physostigmin
(-) physostigmine
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo(2,3-b)indol-5-yl methylcarbamate
Eserine (TN)
Physostigmine (USP)
Spectrum_000916
Spectrum_001789
ESERINUM [HPUS]
SpecPlus_000381
Prestwick0_000566
Prestwick1_000566
Prestwick2_000566
Prestwick3_000566
Spectrum2_000330
Spectrum2_000757
Spectrum2_001283
Spectrum3_000545
Spectrum3_000901
Spectrum4_000997
Spectrum4_001631
Spectrum4_001913
Spectrum5_000441
Spectrum5_000626
Spectrum5_001672
PHYSOSTIGMINE [MI]
physostigmine.salicylic acid
(-)-ESERINE
PHYSOSTIGMINE [HSDB]
Lopac0_000483
SCHEMBL24044
BSPBio_000352
BSPBio_002189
KBioGR_001433
KBioGR_002061
KBioGR_002533
KBioSS_001396
KBioSS_002279
PHYSOSTIGMINE [VANDF]
MLS001304022
DivK1c_006477
SPECTRUM1500753
SPBio_000339
SPBio_000774
SPBio_001285
SPBio_002571
PHYSOSTIGMINE [WHO-DD]
BPBio1_000388
cid_657348
GTPL6598
MEGxp0_001872
ACon1_000097
BDBM11023
KBio1_001421
KBio2_001396
KBio2_002278
KBio2_003964
KBio2_004846
KBio2_006532
KBio2_007414
KBio3_001689
KBio3_001842
HMS1921G06
HMS2089M11
HMS2236L08
HMS3261B07
BCP19735
Carbamic acid, ester with eseroline
HY-N6608
Tox21_111228
Tox21_301591
Tox21_500483
BDBM50004000
BDBM50222010
CCG-38605
AKOS016843649
Tox21_111228_1
DB00981
FE59473
LP00483
SDCCGMLS-0066585.P001
SDCCGSBI-0050467.P005
ESEROLEIN, METHYLCARBAMATE(ESTER)
NCGC00093889-01
NCGC00093889-02
NCGC00093889-04
NCGC00093889-05
NCGC00093889-06
NCGC00093889-07
NCGC00093889-08
NCGC00093889-09
NCGC00093889-10
NCGC00093889-12
NCGC00093889-13
NCGC00093889-20
NCGC00255345-01
NCGC00261168-01
1ST40315
AC-15983
AC-37456
DA-56831
SMR000718753
SBI-0050467.P004
CS-0034353
EU-0100483
NS00004015
P0406
Physostigmine 100 microg/mL in Acetonitrile
C06535
D00196
E 8375
G60920
EN300-23839407
Q410595
Eserine; Antilirium; Physostol; Esromiotin; Ezerin
SR-01000075341-1
WLN: T B556 EN GNTT&J B1 E1 G1 KOVM1
BRD-K25650355-001-02-5
BRD-K25650355-059-02-3
BRD-K25650355-059-12-2
BRD-K25650355-059-18-9
BRD-K25650355-065-02-0
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate hydrochloride
(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid
1,2,3,3A.BETA.,8A.BETA.-HEXAHYDRO-1,3A,8-TRIMETHYLPYRROLO(2,3-B)-INDOL-5-YL METHYLCARBAMATE
200-332-8
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), (3aS,8aR)-
PYRROLO(2,3-B)INDOL-5-OL, 1,2,3,3A,8,8A-HEXAHYDRO-1,3A,8-TRIMETHYL-, METHYLCARBAMATE(ESTER),(3AS-CIS)-
Pyrrolo[2, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-
Solubility of [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate
The solubility of the compound [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate (C15H21N3O2) reflects its unique structure and functional groups. Generally, the solubility of organic compounds can be influenced by their polarity, molecular weight, and the presence of specific functional groups. For this compound:
However, due to its complex structure, the solubility can vary:
Considering these factors, it is important to conduct empirical solubility tests to understand the precise solubility behavior of this compound. As mentioned, "solubility is a complex phenomenon influenced by multiple factors," prompting the need for experimental verification to derive accurate conclusions.